Key result
Review outlines diagnosis and management strategies for common perioperative and outpatient LVAD emergencies.
Highlights the growing importance of diagnosing and managing common perioperative and outpatient LVAD emergencies due to the expanding population of patients with end-stage heart failure.
Durable left ventricular assist devices (LVADs) are a virtually limitless advanced therapy option for an increasingly growing population of patients with end-stage advanced heart failure. As of 2019, 30% to 40% of all patients diagnosed with heart failure were categorized as New York Heart Association class III or IV. In 2018 more than 3.2 million office visits and 1.4 million emergency department visits carried a primary diagnosis of heart failure. Given the rapid growth of the LVAD population, facility in the diagnosis and management of common perioperative and outpatient LVAD emergencies has become of paramount importance in a variety of clinical settings.
No takes yet. Share an insight, caveat, or question.
Sennhauser et al. (2026) conducted a review in End-stage advanced heart failure. Left ventricular assist devices (LVADs) was evaluated. Diagnosis and management of common perioperative and outpatient left ventricular assist device (LVAD) emergencies are of paramount importance given the rapid growth of the LVAD population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: